Curaleaf Forecast, price target & analysts
Curaleaf Target price 2026 - Analyst rating & recommendation
Curaleaf Classifications & Recommendation
Curaleaf Price Target
| Target Price | C$19.00 |
| Price | C$15.65 |
| Potential |
21.39%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target Curaleaf 2027 .
The average Curaleaf target price is C$19.00.
This is
21.39%
register free of charge
C$22.05
40.89%
register free of charge
C$16.16
3.26%
register free of charge
|
|
| A rating was issued by 11 analysts: 10 Analysts recommend Curaleaf to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Curaleaf stock has an average upside potential 2027 of
21.39%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion C$ | 1.79 | 1.97 |
| 4.96% | 9.93% | |
| EBITDA Margin | 13.16% | 20.83% |
| 10.68% | 58.32% | |
| Net Margin | -18.22% | 0.19% |
| 12.86% | 101.04% |
8 Analysts have issued a sales forecast Curaleaf 2026 . The average Curaleaf sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an Curaleaf EBITDA forecast 2026. The average Curaleaf EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 Curaleaf Analysts have issued a net profit forecast 2026. The average Curaleaf net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share C$ | -1.27 | 0.01 |
| 3.25% | 100.79% | |
| P/E | 1,084.67 | |
| EV/Sales | 2.79 |
8 Analysts have issued a Curaleaf forecast for earnings per share. The average Curaleaf EPS is
This results in the following potential growth metrics and future valuations:
Current Curaleaf Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ATB CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Aug 12 2026 |
| ALLIANCE GLOBAL PARTNERS |
Locked
➜
Locked
|
Locked | Aug 12 2026 |
| ROTH CAPITAL PARTNERS |
Locked
➜
Locked
|
Locked | Aug 11 2026 |
| HAYWOOD SECURITIES INC. |
Locked
➜
Locked
|
Locked | Aug 11 2026 |
| CANACCORD GENUITY |
Locked
➜
Locked
|
Locked | Aug 10 2026 |
| CANACCORD GENUITY |
Locked
➜
Locked
|
Locked | Jun 05 2026 |
| CANACCORD GENUITY |
Locked
➜
Locked
|
Locked | Jun 04 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
ATB CAPITAL MARKETS:
Locked
➜
Locked
|
Aug 12 2026 |
|
Locked
ALLIANCE GLOBAL PARTNERS:
Locked
➜
Locked
|
Aug 12 2026 |
|
Locked
ROTH CAPITAL PARTNERS:
Locked
➜
Locked
|
Aug 11 2026 |
|
Locked
HAYWOOD SECURITIES INC.:
Locked
➜
Locked
|
Aug 11 2026 |
|
Locked
CANACCORD GENUITY:
Locked
➜
Locked
|
Aug 10 2026 |
|
Locked
CANACCORD GENUITY:
Locked
➜
Locked
|
Jun 05 2026 |
|
Locked
CANACCORD GENUITY:
Locked
➜
Locked
|
Jun 04 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
